Peer Review History: Telehealth for COVID-19 Pandemic

Editor(s):

(1) Dr. Paola Angelini, University of Perugia, Perugia, Italy.

(2) Dr. Koteshwara Mudigonda, Director of Novel Drug Delivery Systems, Propharmex Company, India.

Reviewers:

(1) Livhuwani Muthelo, University of Limpopo, South Africa.

(2) Surendra Prasad Chaurasiya, Tribhuvan University, Nepal.

(3) Halah H. Al-Haideri, University of Baghdad, Iraq.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.8/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Livhuwani Muthelo, South Africa) | File 1 | NA


Stage 2 | Peer review report_2 (Surendra Prasad Chaurasiya, Nepal) | File 1 | NA


Stage 2 | Peer review report_3 (Halah H. Al-Haideri, Iraq) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA